Effect of supplementation of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemostatic function in healthy subjects.
Hirai
A
A
2nd Department of Internal Medicine, School of Medicine, Chiba University, Japan.
Terano
T
T
Takenaga
M
M
Kobayashi
S
S
Makuta
H
H
Ozawa
A
A
Fujita
T
T
Tamura
Y
Y
Kitagawa
H
H
Kumagai
A
A
D000284:Administration, Oral; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D004281:Docosahexaenoic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D005231:Fatty Acids, Unsaturated / Q000097:blood; D006801:Humans; D008297:Male; D010743:Phospholipids / Q000097:blood; D010974:Platelet Aggregation / Q000187:drug effects
D001095:Arachidonic Acids; D005231:Fatty Acids, Unsaturated; D010743:Phospholipids; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid; D015118:Eicosapentaenoic Acid